AnGes MG Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY39.49 |
Market Cap |
JPY73.46 B |
Shares Outstanding |
106.93 M |
Public Float |
95.87 M |
Address |
Saito Bio-Incubator 1F Osaka Osaka 567 Japan |
Employees | - |
Website | http://www.anges.co.jp |
Updated | 07/08/2019 |
AnGes, Inc. engages in the research and development of gene-based medical products. It offers genetic medicines such as hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, and others. It is also involved in the research and development of medical equipment, which improves blood circulation by regenerating blood vessels and NfkB which controls various inflammations. |